Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort
Author(s) -
Renke Maas,
Vanessa Xanthakis,
Joseph F. Polak,
Edzard Schwedhelm,
Lisa Sullivan,
Ralf A. Benndorf,
Friedrich Schulze,
Ramachandran S. Vasan,
Philip A. Wolf,
Rainer H. Böger,
Sudha Seshadri
Publication year - 2009
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.109.552539
Subject(s) - medicine , cardiology , intima media thickness , asymmetric dimethylarginine , framingham risk score , blood pressure , diabetes mellitus , subclinical infection , endocrinology , carotid arteries , disease , biochemistry , chemistry , amino acid , arginine
Higher plasma concentrations of the endogenous nitric oxides synthase inhibitor asymmetrical dimethylarginine (ADMA) are associated with increased risk of cardiovascular and cerebrovascular events and death, presumably by promoting endothelial dysfunction and subclinical atherosclerosis. We hypothesized that plasma ADMA concentrations are positively related to common carotid artery intimal-media thickness (CCA-IMT) and to internal carotid (ICA)/bulb IMT.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom